Interestingly, pretreatment with the GHSR inverse agonist SP-analog enhances 5-HT2C intracellular receptor signaling, supporting the notion that inverse agonists of the GHSR (and perhaps antagonists) may augment the effectiveness of 5-HT2C in the treatment of schizophrenia. This evidence concerns the gene GHSR and schizophrenia.